Statistical analysis methods for QT/QTc prolongation

被引:4
|
作者
Ma, Haijun [1 ]
Smith, Brian [1 ]
Dmitrienko, Alex
机构
[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
关键词
cardiac repolarization; QTc correction; QTc interval; QT prolongation; thorough QT/QTc study;
D O I
10.1080/10543400801995494
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Prolonged QT interval is associated with life-threatening arrhythmias. Regulatory authorities have paid special attention to investigating the drug-induced delay of cardiac repolarization. Studies aimed at evaluating QT prolongation have become a routine part of safety packages across the pharmaceutical industry. However, the assessment of QT interval prolongation on the surface electrocardiogram is complicated by the fact that many factors influence the duration of the QT interval, among which heart rate plays a predominant role. Some widely used corrections of the QT interval for varying heart rate are known to be inadequate. Many alternatives have been proposed in the literature. Using information obtained from Eli Lilly thorough QT studies, we examine the performance of several approaches to the analysis of QT changes, including subject-specific (individual) QT corrections and model-based QT analysis methods. The simulation results indicate that the mixed-effects modeling approach proposed in this paper is more powerful than the other methods, all of which are commonly used in QT studies.
引用
收藏
页码:553 / 563
页数:11
相关论文
共 50 条
  • [1] Statistical assessment of QT/QTc prolongation based on maximum of correlated normal random variables
    Cheng, Bin
    Chow, Shein-Chung
    Burt, David
    Cosmatos, Dennis
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2008, 18 (03) : 494 - 501
  • [2] The importance of QT/QTc prolongation: A case study
    Agin, MA
    DRUG INFORMATION JOURNAL, 2005, 39 (04): : 385 - 386
  • [3] The Importance of QT/QTc Prolongation: A Case Study
    Marilyn A. Agin
    Drug information journal : DIJ / Drug Information Association, 2005, 39 (4): : 385 - 386
  • [4] The assessment of drug induced QT interval prolongation in healthy subjects:: QTc interval, QT (QTc) dispersion?
    Nemat, S
    Prasad, V
    Oliver, S
    Hedge, A
    Amakye, D
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 90 - 90
  • [5] Statistical Characterization of QT Prolongation
    Schall, Robert
    Ring, Arne
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2010, 20 (03) : 543 - 562
  • [6] Absence of QTc prolongation with semaglutide: a thorough QT/QTc study in healthy subjects
    Demmel, V.
    Sandberg-Schaal, A.
    Jacobsen, J. B.
    Golor, G.
    Flint, A.
    Pettersson, J.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1128 - 1129
  • [7] No QTc Prolongation With Zanubrutinib: Results of Concentration-QTc Analysis From a Thorough QT Study in Healthy Subjects
    Mu, Song
    Darpo, Borje
    Tang, Zhiyu
    Novotny, William
    Tawashi, Manal
    Xue, Hongqi
    Willett, Michael
    Lin, Leo
    Sahasranaman, Sri
    Ou, Ying C.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (05): : 923 - 931
  • [8] No QTc Prolongation with Semaglutide: A Thorough QT Study in Healthy Subjects
    Valentin Demmel
    Anne Sandberg-Schaal
    Jacob B. Jacobsen
    Georg Golor
    Jonas Pettersson
    Anne Flint
    Diabetes Therapy, 2018, 9 : 1441 - 1456
  • [9] QT/QTc prolongation in placebo-treated subjects: A PhRMA collaborative data analysis
    Agin, Marilyn A.
    Aronstein, William S.
    Ferber, Georg
    Geraldes, Margarida C.
    Locke, Charles
    Sager, Philip
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2008, 18 (03) : 408 - 426
  • [10] No QTc Prolongation with Semaglutide: A Thorough QT Study in Healthy Subjects
    Demmel, Valentin
    Sandberg-Schaal, Anne
    Jacobsen, Jacob B.
    Golor, Georg
    Pettersson, Jonas
    Flint, Anne
    DIABETES THERAPY, 2018, 9 (04) : 1441 - 1456